RHONDA SANDERS: Open Payments
NPI 1093711699 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 28 payments from 9 companies in 2025. Trend: 2023 $605 · 2024 $875 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $199 |
| Evofem Biosciences, Inc. | 6 | $107 |
| MILLICENT US INC | 4 | $88 |
| Exeltis, USA Inc. | 4 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $27 |
| Smith+Nephew, Inc. | 1 | $24 |
| Organon LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: ZURZUVAE, Phexxi, SLYND, FEMLYV, MYFEMBREE, FEMRING, PICO 7, NEXPLANON.
Industry payments across TX — which companies pay providers there.
